<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221224056907N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-31</date_registration>
      <primary_sponsor>University of social welfare and rehabilitation sciences</primary_sponsor>
      <public_title>Effect of virtual reality games in autism spectrum disorder (ASD)</public_title>
      <acronym></acronym>
      <scientific_title>The comparison between the effectiveness of using virtual reality games and conventional intervention on social-communication skills of school-aged children with autism spectrum disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67577</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The blocked randomization method is used to allocate participants to two groups. This allocation is done in several step. First, using the online software
application provided by sealedenvelope.com, a random sequence is generated with blocks of four. Then, to hide the random allocation, sequentially numbered, opaque sealed envelopes (SNOSE) are used in a random sequence. Based on the sample size, 32 envelopes with aluminum foil inside (to prevent ''hot lighting'') are prepared. Each entity in the random sequence is noted on a card and is replaced in the envelope in numbered envelope. Finally, the envelopes are sealed and placed in boxes, respectively. At the time of registration of participants, according to the order of entry of eligible participants into the study, one of the envelopes is opened respectively and so the participant's assigned group is revealed. In this approach, the experts who check the inclusion and exclusion criteria and the experts who do the allocation process are independent, Blinding description: The study is double-blind and participants and assessors will be blinded to randomized group allocation. Children in the intervention group will receive joint attention tasks through virtual reality (VR) games with VR glasses, while children in the control group will use VR glasses only to watch a simple animation. Furthermore, both groups receive the conventional speech and language therapy during the experiment.  
The assessors are also not aware of which intervention participants have received and whether the assessments are pre- or post intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Autism spectrum disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Virtual reality games in order to make improvement joint attention through VR glasses, 15 sessions with an interval of 48 hours, three sessions per week, each session includes one or two virtual reality games, and the duration of each game is about five minutes. There is a three to five minute break between each game. Intervention 2: Control group: A simple animation through VR glasses, 15 sessions with an interval of 48 hours, three sessions per week, each session includes one or two animations with virtual reality characters, and the duration of each animation is about five minutes. There is a three to five minute break between each animation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The results of this study will be published in peer-reviewed journals.

When:
After publishing results

To whom:
Academic researchers

Conditions:
Data will be available only for research purpose.

Where to obtain:
Through sending an email to:
hassanyazdanian@gmail.com

How to obtain:
The requested data will be sent as soon as possible after receiving the email.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hassan Yazdanian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 6, No. 25, Qods St., Eneghelab Ave., Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1417743157</zip>
        <telephone>+98 21 8612 6317</telephone>
        <email>hassanyazdanian@gmail.com</email>
        <affiliation>Tose'e Darman Sarv</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Talieh Zarifian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Speech Therapy Department, University of Social Welfare and Rehabilitation Sciences, Koudakyar Ave. Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985713871</zip>
        <telephone>+98 21 2218 0139</telephone>
        <email>ta.zarifian@uswr.ac.ir</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Monolingual in Persian
Parents consent for inclusion in the experiment
A clinical diagnosis of autism spectrum disorder (ASD)</inclusion_criteria>
      <agemin>7 years</agemin>
      <agemax>11 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of problems with virtual reality games
History of seizures, epilepsy, migraines, vertigo, psychosis, or photophobia
Obvious vision or hearing problem
Severe stereotyped behaviors and hyperactivity
Severe sensory or balance impairments
Inability to understand and follow simple instructions
Lack of proper psychomotor development</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F84.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Autistic disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Virtual reality games in order to make improvement joint attention through VR glasses, 15 sessions with an interval of 48 hours, three sessions per week, each session includes one or two virtual reality games, and the duration of each game is about five minutes. There is a three to five minute break between each game.</i_keyword>
      <i_keyword>Control group: A simple animation through VR glasses, 15 sessions with an interval of 48 hours, three sessions per week, each session includes one or two animations with virtual reality characters, and the duration of each animation is about five minutes. There is a three to five minute break between each animation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Joint attention skills. Timepoint: Assessment of joint attention skills at the beginning of the study (baseline, before the start of the intervention), at the end of the study and one month after the end of the study (follow-up). Method of measurement: Floreo questionnaire; pre- and post-assessment game.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Social-communication skills. Timepoint: Assessment of joint attention skills at the beginning of the study (baseline, before the start of the intervention), at the end of the study and one month after the end of the study (follow-up). Method of measurement: Autism Classification System of Functioning: Social Communication (ACSF: SC).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of social welfare and rehabilitation sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-21</approval_date>
        <contact_name>Research Ethics Committees of University of Social Welfare and Rehabilitation Sciences</contact_name>
        <contact_address>Kodakyar Ave., Daneshjo Blvd., Evin, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
